61727-353 NDC - BLADDER IRRITATION AND UTI (CANTHARIS, CLEMATIS, CUBEBA, ECHINACEA, RANUNCULUS BULBOSUS, SABAL SER, STAPHYSAGRIA, UVA URSI)

Drug Information

Product NDC: 61727-353

Proprietary Name: Bladder Irritation and UTI

Non Proprietary Name: Cantharis, Clematis, Cubeba, Echinacea, Ranunculus bulbosus, Sabal ser, Staphysagria, Uva ursi

Active Ingredient(s):
  • 6 [hp_X]/601 ARCTOSTAPHYLOS UVA-URSI LEAF;
  • 6 [hp_X]/601 CLEMATIS RECTA FLOWERING TOP;
  • 6 [hp_X]/601 DELPHINIUM STAPHISAGRIA SEED;
  • 6 [hp_X]/601 ECHINACEA ANGUSTIFOLIA;
  • 6 [hp_X]/601 LYTTA VESICATORIA;
  • 6 [hp_X]/601 PIPER CUBEBA FRUIT;
  • 6 [hp_X]/601 RANUNCULUS BULBOSUS;
  • 6 [hp_X]/601 SERENOA REPENS WHOLE


Administration Route(s): ORAL

Dosage Form(s): TABLET, CHEWABLE

Labeler Information

Labeler Name: HomeoCare Laboratories, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:3/19/2019

Package Information

No. Package Code Package Description Billing Unit
161727-353-6060 TABLET, CHEWABLE in 1 BOTTLE (61727-353-60)

NDC Record

Field Name Field Value Definition
PRODUCT NDC61727-353The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEBladder Irritation and UTIThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECantharis, Clematis, Cubeba, Echinacea, Ranunculus bulbosus, Sabal ser, Staphysagria, Uva ursiThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLET, CHEWABLEThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE3/19/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEHomeoCare Laboratories, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEARCTOSTAPHYLOS UVA-URSI LEAF; CLEMATIS RECTA FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA ANGUSTIFOLIA; LYTTA VESICATORIA; PIPER CUBEBA FRUIT; RANUNCULUS BULBOSUS; SERENOA REPENS WHOLEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 6; 6; 6; 6; 6; 6; 6 
ACTIVE INGRED UNIT[hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023